prof. dr. Jan De Bleecker
- ORCID iD
- 0000-0002-1328-1812
Show
Sort by
-
- Conference Paper
- C3
- open access
Ectoine treatment stimulates protein markers of autophagy efficiency in the Duchenne muscular dystrophy mouse model mdx
(2024) JOURNAL OF NEUROLOGY AND EXPERIMENTAL NEUROSCIENCE. In Journal of Neurology and Experimental Neuroscience 10(Supplement 1). p.S8-S9 -
272nd ENMC international workshop : 10 years of progress : revision of the ENMC 2013 diagnostic criteria for inclusion body myositis and clinical trial readiness. 16-18 June 2023, Hoofddorp, The Netherlands
-
Experiences with advance care planning in amyotrophic lateral sclerosis : qualitative longitudinal study with people with amyotrophic lateral sclerosis and their family carers
-
Potential new autoimmune target in inclusion body myositis
(2024) CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. In Clinical and Experimental Rheumatology 42(2). p.505-506 -
- Journal Article
- A1
- open access
Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+) : interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis
-
- Journal Article
- A1
- open access
Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis : results from the MYONET registry
(2024) RHEUMATOLOGY. -
Anoctamin-5 related muscle disease : clinical and genetic findings in a large European cohort
-
- Journal Article
- A1
- open access
Retrospective study shows that serum levels of chemokine CXCL10 and cytokine GDF15 support a diagnosis of sporadic inclusion body myositis and immune-mediated necrotizing myopathy
-
- Journal Article
- A1
- open access
Identification of novel associations and localization of signals in idiopathic inflammatory myopathies using genome‐wide imputation
-
Wat zijn de ervaringen van personen met amyotrofische laterale sclerose (ALS) en hun mantelzorgers met vroegtijdige zorgplanning?